Amniotic Membrane Market Analysis
The Global Amniotic Membrane Market size will surpass US$ 6.58 billion by 2032 from US$ 2.43 billion in 2023, with a CAGR of 11.68% from 2024 to 2032. Some of the main reasons driving the market include the growing demand for minimally invasive (MI) treatments, the rise in the prevalence of various chronic illnesses like rheumatoid arthritis and diabetes, and the growth of specialist clinics and hospitals.
Amniotic Membrane Market Outlook
The placenta's interior most layer, the amniotic membrane, is made up of an avascular stromal matrix and a thick foundation membrane. Because of its special qualities, this biological tissue - which comes from the placenta - is used in medical applications. By controlling inflammatory reactions, it lessens tissue fibrosis and scarring while also reducing inflammation. It shortens the healing times of burns and severe wounds by relaxing them. It is frequently utilized in procedures for conditions affecting the ocular surface, like corneal ulcers, it is safe, well-tolerated, and has a low rejection rate. It is also used as a biological dressing to improve healing and lessen adhesions.The amniotic membrane is being used in more surgical operations as a result of patients' growing demand for minimally invasive (MI) therapies. Amniotic membrane therapy implementation is also becoming increasingly feasible due to the development of specialized clinics and hospitals, as well as the expansion of the healthcare infrastructure. In addition, in order to broaden their reach, exchange knowledge, and penetrate new markets, a number of prominent industry participants are concentrating on mergers and acquisitions (M&A). Additionally, businesses are continuously expanding the range of products they offer, including amniotic membranes customized for different surgical and medicinal applications. Additionally, a number of nations' governments are stepping up their campaigns to inform medical professionals and people about the uses and advantages of amniotic membranes, which is promising for the industry.
Driving Forces of Global Amniotic Membrane Market:
The market is expanding because to the increased prevalence of burn injuries:
The rising demand for biologics used in wound treatment, such as amniotic membranes, is propelling the growth of the amniotic membrane market. Nearly two-thirds of burn cases occur in the WHO's African and Southeast Asian regions, and the majority happen in low- and middle-income economies. For example, every year in India, one million people suffer from mild to severe burns. Bangladesh and Nepal are two more Southeast Asian countries with significant burn incidence rates. Every year, 173,000 children in Bangladesh are thought to have moderate to severe burns. Burns rank second most common type of wound in Nepal, making up 5% of all impairments.Furthermore, the frequency of transplants has increased in recent years due to increased awareness, which has raised demand for these tissue-based therapies. Additionally, as more people become aware of the need for donations, market revenue has grown. As an illustration, Amniox Medical, Inc., a Tissue Tech, Inc. company that pioneered the clinical use of human birth tissue products, debuted a new awareness campaign in June 2021 that highlighted the company's extensive line of human birth tissue-based products designed to speed up wound healing and reduce associated medical costs. The campaign examines the financial burden that treating complicated wounds places on healthcare systems and emphasizes evidence-based quality management.
It is anticipated that an increase in R&D efforts to create new products and boost amniotic membrane efficacy would contribute to the market's expansion. For example, American regenerative medicine company Amnio Technologies began Phase II clinical trials in November 2020 to investigate the effectiveness of their product, PalinGen, an amniotic membrane allograft used to treat diabetic ulcers.
An increase in the population that is older:
The treatment of numerous eye surface infections, such as ocular dystrophy, cataracts, corneal ulcers, bacterial keratitis, glaucoma, bullous keratopathy, corneal degeneration, eyelid reconstruction, and more, is greatly aided by these tissue-based therapies. There is a considerable demand for these items as a result of the enormous increase in ophthalmology surgery caused by the global aging population. According to data released by the Centers for Disease Control and Prevention (CDC), about one million people suffer from eye infections each year.It is primarily used as a biological bandage for wound care and treatment, as well as a surgical transplant. These membranes function as a supporting scaffold to aid in the process of re-epithelization when employed as a graft. Accordingly, Amniox Medical launched an awareness campaign in June 2021 to highlight the usefulness of its tissue-based solutions in lowering the expenses related to wound healing. These drugs, with their anti-inflammatory and anti-scarring qualities, are very helpful in reducing patients' increased discomfort and inflammation, especially in situations of burn injuries.
North America Amniotic Membrane Market
Because of its highly established healthcare infrastructure, significant healthcare expenditures, and recent developments by market competitors, North America is the largest regional market in terms of revenue. For example, the United States Centers for Medicare & Medicaid Services released statistics in February 2023 that shows that, in comparison to 2020, national healthcare spending climbed by 2.7% to USD 4.3 trillion in 2021.Furthermore, it is projected that the major innovations made by industry participants will accelerate market expansion in North America. For example, TissueTech was granted approval by the Food and Drug Administration (FDA) in March 2021 to carry out a Phase 2 trial employing cryopreserved umbilical cord (CUC) and cryopreserved amniotic membrane (CAM) that has been morselized (IND# TTBT01).
Once more, in May 2021, Vivex Biologics, Inc. - a premier provider of naturally sourced therapies in the field of regenerative medicine - introduced Viagenex, a line of amniotic allografts that are processed to preserve the rich supply of extracellular matrix, growth factors, and cytokines as well as the intrinsic mechanical properties of amniotic tissue. As a result, the region's amniotic membrane market is anticipated to rise as a result of the intense product development taking place in several North American nations.
Global Amniotic Membrane Company Analysis:
Some leading Amniotic Membrane companies are Stryker Corporation, Smith & Nephew plc, Integra LifeSciences Holdings, MiMedx, Organogenesis Net, Wright Medical Group Inc, Applied Biologics LLC, FzioMed Inc, Katena, Inc., Tissue-Tech Inc.Global Amniotic Membrane Company News:
March 2023: NuVision, a Nottingham-based health technology business, has secured £1.1 million in funding for its inner layer of the placenta-based contact lenses and wound dressing.November 2022: Verséa Ophthalmics introduced a number of products, one of which is the Biovance, a hybrid next-generation amniotic membrane made up of three layers of amnion.
February 2022: Amnio Technology, a pioneer in the creation and marketing of amniotic tissue allografts worldwide, has introduced two new palingen membrane products: dual-layer palingen x-membrane and palingen dual-layer membrane. The novel allografts are homologous usage, chorion-free, and require little modification, just like the rest of the PalinGen membrane product line. Patients with complex and/or open surgical wounds, burns, and non-healing acute and chronic wounds might consider the use of the Palingen dual-layer membrane and the PalinGen X-membrane.
January 2022: Akorn Operating Company LLC and Laboratoires Thea SAS, one of the top independent pharmaceutical companies in Europe, have entered into a purchase agreement for seven branded ophthalmic products, including AcellFX (acellular amniotic membrane), which offers an environment or covering that protects the ocular surface while it is being repaired.
Product -Market Breakup in 2 Viewpoints :
1. Cryopreserved Amniotic Membrane2. Lyophilization Amniotic Membrane
Application - Market Breakup in 3 Viewpoints :
1. Surgical Wounds2. Ophthalmology
3. Others
End Users - Market Breakup in 4 Viewpoints :
1. Hospital2. Ambulatory Surgical Centers
3. Speciality Clinics
4. Research & Academic Institutes
Geography - Market Breakup of 23 countries :
- North America
- United States
- Canada
- Colombia
- Europe
- France
- Germany
- Italy
- Spain
- United Kingdom
- Netherlands
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Malaysia
- Indonesia
- Israel
- Latin America
- Brazil
- Mexico
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- ROW
Company Insights:
- Overview
- Recent Development
- Product Portfolio
- Revenue
Key Players Analysis:
1. Stryker Corporation2. Smith & Nephew plc
3. Integra LifeSciences Holdings
4. MiMedx
5. Organogenesis Net
6. Wright Medical Group Inc
7. Applied Biologics LLC
8. FzioMed Inc
9. Katena, Inc.
10. Tissue-Tech Inc
Table of Contents
1. Introduction2. Research Methodology3. Executive Summary5. SWOT Analysis6. Amniotic Membrane Market
4. Market Dynamics
7. Amniotic Membrane Market - Share Analysis
8. Amniotic Membrane Market - By product
9. Amniotic Membrane Market - By Application
10. Amniotic Membrane Market - By End User
11. Amniotic Membrane Market - By Country
12. Key Players
Companies Mentioned
- Stryker Corporation
- Smith & Nephew plc
- Integra LifeSciences Holdings
- MiMedx
- Organogenesis Net
- Wright Medical Group Inc
- Applied Biologics LLC
- FzioMed Inc
- Katena, Inc.
- Tissue-Tech Inc
Methodology
In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.
Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.
Primary Research
The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develop the analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth, and forecast
The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:
- Chief executives and VPs of leading corporations specific to the industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
- Key opinion leaders (KOLs)
Secondary Research
The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, webcasts, and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | July 2024 |
| Forecast Period | 2023 - 2032 |
| Estimated Market Value ( USD | $ 2.44 Billion |
| Forecasted Market Value ( USD | $ 6.59 Billion |
| Compound Annual Growth Rate | 11.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
